TXG Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - 10X Genomics Inc

Watchlist Manager

Watchlist

Price: 29.59 USD 4.54% Market Closed

Market Cap: $3.8B

	10X Genomics Inc NASDAQ:TXG	US
	Panin Financial Tbk PT IDX:PNLF	ID
	Farmers National Banc Corp NASDAQ:FMNB	US
	Wisekey International Holding AG NASDAQ:WKEY	CH
B	BETA Technologies Inc NYSE:BETA	US
	Carvana Co NYSE:CVNA	US
T	Transurban Group OTC:TRAUF	AU
	Betmakers Technology Group Ltd ASX:BET	AU
N	Nyocor Co Ltd SSE:600821	CN
S	Sumitomo Chemical Co Ltd DUS:SMM	JP
T	TimkenSteel Corp NYSE:MTUS	US
B	Bitcoin Depot Inc NASDAQ:BTM	US
E	EDP Renovaveis SA XMUN:EDW	ES
V	Viant Technology Inc NASDAQ:DSP	US
	Symphony Ltd NSE:SYMPHONY	IN

Profitability Summary

10X Genomics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

68%

Declining Gross Margin

76% > 70%

Negative Operating Margin

-11%

Negative 3Y Average Operating Margin

-28%

Operating Margin is Increasing

-33% > -11%

Negative Net Margin

-4%

Negative 3Y Average Net Margin

-26%

Net Margin is Increasing

-33% > -4%

Exceptional Free Cash Flow Margin

20%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-23% > 20%

Negative ROE

-3%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-34%

ROIC is Increasing

-36% > -17%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.